Skip to main content
. 2018 Jul 14;2(3):126–131. doi: 10.1093/jcag/gwy036

Table 3.

Response rate by indication for BFT and by response type

Indication Response type Response rate (%)
All indications
(n=130)
ARM and symptom 64/130 (49.2%)
ARM alone 27/130 (20.7%)
Symptoms alone 8/130 (6.2%)
ARM and/or symptom 99/130 (76.2%)
Symptoms with or without ARM response 72/130 (55.4%)
No response 31/130 (23.8%)
CC with DD
(n=53)
ARM and symptom 21/53 (39.6%)
ARM alone 13/53 (24.5%)
Symptoms alone 3/53 (5.7%)
ARM and/or symptom 37/53 (69.8%)
Symptoms with or without ARM response 24/53 (45.3%)
No response 16/53 (30.2%)
CC without DD
(n=3)
ARM and symptom 0/3 (0%)
ARM alone 2/3 (66.7%)
Symptoms alone 0/3 (0%)
ARM and/or symptom 2/3 (66.7%)
Symptoms with or without ARM response 0/3 (0%)
No response 1/3 (33.3%)
FI
(n=49)
ARM and symptom 31/49 (63.3%)
ARM alone 6/49 (12.2%)
Symptoms alone 2/49 (4.1%)
ARM and/or symptom 39/49 (79.6%)
Symptoms with or without ARM response 33/49 (67.3%)
No response 10/49 (20.4%)
Alternating FI/CC
(n=22)
ARM and symptom 12/22 (54.5%)
ARM alone 4/22 (18.2%)
Symptoms alone 3/22 (13.6%)
ARM and/or symptom 19/22 (86.4%)
Symptoms with or without ARM response 15/22 (68.2%)
No response 3/22 (13.6%)
Rectal pain
(n=3)
ARM and symptom 0/3 (0%)
ARM alone 2/3 (66.7%)
Symptoms alone 0/3 (0%)
ARM and/or symptom 2/3 (66.7%)
Symptoms with or without ARM response 0/3 (0%)
No response 1/3 (33.3%)